I would have hoped for a 3 buck price after the phase IIb results. We are seeing some sustained buying but it is at low volume. I'm keeping a watchful eye on volume as ultimately it will reveal buying intention. Although takeover could come out of the blue.
Inavir royalty announcement shortly, another few mil for the kitty can't hurt.
- Forums
- ASX - By Stock
- BTA
- busting the niche market myth for vapendavir
busting the niche market myth for vapendavir, page-5
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)